NewCardio Retained Earnings (Accumulated Deficit) 2010-2011 | NWCI

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

NewCardio retained earnings (accumulated deficit) from 2010 to 2011. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.

NewCardio Retained Earnings (Accumulated Deficit) 2010-2011 | NWCI

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$206.8B
Intuitive Surgical (ISRG)	$191.3B
Alcon (ALC)	$42.9B
Edwards Lifesciences (EW)	$38.8B
IQVIA Holdings (IQV)	$38.8B
IDEXX Laboratories (IDXX)	$34.9B
DexCom (DXCM)	$29B
Waters (WAT)	$22.9B
STERIS (STE)	$22B
SONOVA HOLDING (SONVY)	$21.6B
Hologic (HOLX)	$18.5B
Sysmex ADR (SSMXY)	$12.6B
Fresenius Medical Care AG KGaA (FMS)	$12.4B
Globus Medical (GMED)	$11.3B
Teleflex (TFX)	$9.1B
Penumbra (PEN)	$9.1B
Masimo (MASI)	$8.6B
Glaukos (GKOS)	$7.9B
PROCEPT BioRobotics (PRCT)	$5B
Integer Holdings (ITGR)	$4.6B
TransMedics (TMDX)	$3.1B
Inari Medical (NARI)	$3B
Veracyte (VCYT)	$3B
LivaNova (LIVN)	$2.9B
Nihon Kohden (NHNKY)	$2.6B
Elekta AB (EKTAY)	$2.3B
Tandem Diabetes Care (TNDM)	$2B
Integra LifeSciences Holdings (IART)	$1.9B
RxSight (RXST)	$1.8B
Alphatec Holdings (ATEC)	$1.3B